# Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy

> **NCT00052221** · NA · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Fatigue
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** Epoetin alfa
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00052221
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2003-05-20
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00052221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00052221, "Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00052221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*